Table III.
OS | DFS | |||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
Tumor | 1.54 (1.23–1.93) | 0.002 | 1.21 (0.82–1.80) | 0.337 | 1.59 (1.26–2.00) | <0.001 | 1.44 (0.94–2.22) | 0.094 |
Stage | 2.60 (1.62–4.17) | <0.001 | 0.79 (0.27–2.30) | 0.660 | 2.63 (1.63–4.25) | <0.001 | 0.57 (0.18–1.77) | 0.329 |
Histological grade | 3.32 (1.58–7.00) | 0.002 | 3.10 (1.20–8.01) | 0.020 | 3.29 (1.58–6.83) | 0.002 | 2.38 (0.89–6.37) | 0.084 |
Lymph node metastasis | 8.34 (2.75–25.3) | 0.002 | 2.47 (0.60–10.1) | 0.210 | 7.83 (2.61–23.5) | <0.001 | 2.45 (0.55–10.9) | 0.240 |
MIB-1 labeling index | 2.56 (0.34–19.5) | 0.364 | 2.85 (0.38–21.7) | 0.311 | ||||
ELP3 expression | 0.19 (0.07–0.52) | 0.001 | 0.24 (0.07–0.79) | 0.019 | 0.21 (0.08–0.57) | 0.002 | 0.33 (0.10–1.11) | 0.073 |
HR, hazard ratio; CI, confidence interval.